​

Funding Round

Series B - Moximed

Series B - Moximed

Investment Firm

Overview

Moximed develops innovative therapies for patients with knee osteoarthritis.

Announced Date

Jan 27, 2016

Closed on Date

Jan 27, 2016

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

New Enterprise Associates

New Enterprise Associates

New Enterprise Associates is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

3

Investor Name
Participant InvestorGilde Healthcare
Participant InvestorGBS Ventures
Participant InvestorNew Enterprise Associates

Round Details and Background

Moximed raised $12617182 on 2016-01-27 in Series B

Moximed develops innovative therapies for patients with knee osteoarthritis.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 27, 2016
Series B - Moximed
3-12.6M
May 07, 2015
Series B - Moximed
6-33.0M
Jan 01, 2012
Venture Round - Moximed
4-1.8M
Dec 05, 2011
Series A - Moximed
-45.8M

Recent Activity

There is no recent news or activity for this profile.